Prescription drug · ANDA
Penicillamine NDC 68475-201
Penicillamine 250 mg/1 · Capsule · Oral · Navinta LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68475-201-01 | 6847502010168475020101 | 100 CAPSULE in 1 BOTTLE (68475-201-01)Marketed from Jan 1, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Penicillamine
- Generic name (nonproprietary)
- penicillamine
- Active ingredients
- Penicillamine — 250 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Navinta LLCNDC labeler code 68475
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214363
- Marketing start
- Listing expires
- Identifiers
- Product ID 68475-201_0ee5ea02-a892-408f-aa5d-42ab034bdfc4SPL ID 0ee5ea02-a892-408f-aa5d-42ab034bdfc4SPL set ID 064fb48d-aa34-4e52-9295-10f2ca4c77dcRxCUI 198070UNII GNN1DV99GX
- Pharmacologic class
- Antirheumatic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468475020101followed by a unit qualifier and the quantityPackage 68475-0201-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Penicillamine capsules are indicated in the treatment of Wilson's disease, cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy. Available evidence suggests that penicillamine capsules are not of value in ankylosing spondylitis. Wilson’s Disease Wilson's disease (hepatolenticular degeneration) occurs in individuals who have inherited an autosomal-recessive defect that leads to an accumulation of copper far in excess of metabolic requirements. The excess copper is deposited in several organs and tissues, and eventually produces pathological effects primarily in the liver, where damage progresse…
Excerpt only. Read the full label for complete information.
About NDC 68475-201
- What is NDC 68475-201?
- 68475-201 is the product NDC for Penicillamine, Penicillamine 250 mg/1 capsule, listed with the FDA by Navinta LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Penicillamine.
- What is the active ingredient?
- Penicillamine.
- Who is the labeler?
- Navinta LLC, NDC labeler code 68475. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Penicillamine?
- 8 other product NDCs are listed under this name. See all Penicillamine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Penicillamine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | Breckenridge Pharmaceutical, Inc. | 51991-974 | 51991-0974-01 |
| Penicillamine | Penicillamine 250 mg/1 | TabletOral | Lupin Pharmaceuticals, Inc. | 70748-153 | 70748-0153-01 |
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | Granules Pharmaceuticals Inc. | 70010-907 | 70010-0907-01 |
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | Proficient Rx LP | 71205-916 | 71205-0916-00 |
| Penicillamine | Penicillamine 250 mg/1 | Capsule, Gelatin coatedOral | Dr. Reddy's Laboratories Inc. | 43598-634 | 43598-0634-01 |
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | Par Health USA, LLC | 49884-146 | 49884-0146-01 |
| penicillamine | Penicillamine 250 mg/1 | Tablet, Film coatedOral | Par Health USA, LLC | 0254-2000 | 00254-2000-01 |
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | Actavis Pharma, Inc. | 0591-4171 | 00591-4171-01 |